Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C2H3O2.Pb.3H2O |
| Molecular Weight | 381.3 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.[PbH2++].CC([O-])=O.CC([O-])=O
InChI
InChIKey=YCFCGUGOMKHROF-UHFFFAOYSA-L
InChI=1S/2C2H4O2.3H2O.Pb.2H/c2*1-2(3)4;;;;;;/h2*1H3,(H,3,4);3*1H2;;;/q;;;;;+2;;/p-2
| Molecular Formula | C2H4O2 |
| Molecular Weight | 60.052 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | H2O |
| Molecular Weight | 18.0153 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Pb |
| Molecular Weight | 209.2 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| A review of selected chemical additives in cosmetic products. | 2014-07-24 |
|
| The protective effect of flaxseed oil on lead acetate-induced renal toxicity in rats. | 2011-10-30 |
|
| Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing. | 2011-03 |
|
| Scope and mechanism of intramolecular aziridination of cyclopent-3-enyl-methylamines to 1-azatricyclo[2.2.1.0(2,6)]heptanes with lead tetraacetate. | 2009-08-26 |
|
| Hypertrophy and increased glial fibrillary acidic protein are coupled to increased protection against cytotoxicity in glioma cell lines. | 1998-04 |
|
| Clastogenicity evaluation of seven chemicals commonly found at hazardous industrial waste sites. | 1989-12 |
|
| Chromosomal effects of lead: A critical review. | 1980 |
|
| The mechanism of the lead tetraacetate oxidation of a B-norsteroid. | 1967-08-15 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20654395
It was examined the associations of increased glial fibrillary acidic protein (GFAP) levels and hypertrophie changes with susceptibility to toxic insult in C6 rat glioma cells. The cells were treated with serial pulses of dibutyryl-cAMP (dBcAMP) (each 48 hr) which increased levels of GFAP approximately twofold and the surface to volume ratio by approximately 1.7 times after the third pulse. This treatment reduced cell number by 22% and increased total protein by 10%. The cells were then exposed to different toxic substances [tin chloride, lead tetraacetate, chloroquine, cadmium chloride, aluminium chloride, mercuric chloride, acrylamide, triethyltin bromide, ethylenediaminetetraacetatic acid (EDTA)] and toxicity to the cells measured by the neutral red (NR) assay. With the exceptions of aluminium chloride and EDTA, 50% effective concentration (EC(50)) values for the toxic substances were increased up to 10,000 times (for cadmium chloride).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:45:29 GMT 2025
by
admin
on
Mon Mar 31 17:45:29 GMT 2025
|
| Record UNII |
RX077P88RY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EPA PESTICIDE CODE |
48001
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
134688182
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
PRIMARY | |||
|
m6722
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
PRIMARY | Merck Index | ||
|
C008261
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
PRIMARY | |||
|
1423667
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
PRIMARY | RxNorm | ||
|
RX077P88RY
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
PRIMARY | |||
|
RX077P88RY
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
PRIMARY | |||
|
6080-56-4
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
PRIMARY | |||
|
300000052861
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
PRIMARY | |||
|
33112
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
PRIMARY | |||
|
31767
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
PRIMARY | |||
|
DTXSID3031521
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
PRIMARY | |||
|
SUB14335MIG
Created by
admin on Mon Mar 31 17:45:29 GMT 2025 , Edited by admin on Mon Mar 31 17:45:29 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ANHYDROUS->SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |